Team CHM


Team CHM

Complex Human Ex Vivo Models of Tissue Inflammation

Arteries play a crucial role in maintaining health and are compromised in various diseases, from diabetes to hypertension. Yet, in vitro, arterial models represent an unmet need to understand disease progression and develop therapeutics. Our group is bridging this gap by generating a 3D in vitro system with sufficient complexity to recapitulate key characteristics of disease onset, progression, and resolution. We will deploy this organotypic human arterial model to identify key markers of disease progression and test promising therapeutics with the long-term goal of advancing patient treatment. Our model can be applied to many forms of vasculitis, including giant cell arteritis, an aging-associated inflammatory disease that can cause stenosis or aneurysm of the affected arteries and lead to sudden blindness.

  • Dr. Sarah Wilson
    Principal Research Scientist I, Pharmacology and Pathology, AbbVie (Industry mentor)
  • TBD
    (Academic mentor)

The research of this team is kindly sponsored by AbbVie.

Our Team Members

Dr. Alicia Cutler

Group Leader

 Short Bio
  • 2022 – 2023: Research Associate, Molecular, Cell, and Developmental Biology Department, University of Colorado Boulder, Boulder, Colorado, USA
  • 2017 – 2022: Postdoc in stem cell biology with Prof. Brad Olwin, University of Colorado Boulder, Boulder, Colorado, USA
  • 2012 – 2017: PhD in Biochemistry with Prof. Grace Pavlath and Prof. Anita Corbet, Emory University, Atlanta, Georgia, USA

Jack Parker

Research Assistant

 Short Bio
  • 2019 – 2023: Bachelor of Science in Ecology & Evolutionary Biology, Yale University, New Haven, Connecticut, USA.
    • Honors thesis focused on human-specific fibroblast behavior in wound healing